These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 34470492
1. Ultrasound-Guided BoNT-A (Botulinum Toxin A) Injection Into the Subscapularis for Hemiplegic Shoulder Pain: A Randomized, Double-Blind, Placebo-Controlled Trial. Tan B, Jia L. Stroke; 2021 Dec; 52(12):3759-3767. PubMed ID: 34470492 [Abstract] [Full Text] [Related]
2. Effect of ultrasound-guided injection of botulinum toxin type A into shoulder joint cavity on shoulder pain in poststroke patients: study protocol for a randomized controlled trial. Zheng P, Shi Y, Qu H, Han ML, Wang ZQ, Zeng Q, Zheng M, Fan T. Trials; 2024 Jun 27; 25(1):418. PubMed ID: 38937804 [Abstract] [Full Text] [Related]
3. Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide. Lim JY, Koh JH, Paik NJ. Stroke; 2008 Jan 27; 39(1):126-31. PubMed ID: 18048857 [Abstract] [Full Text] [Related]
4. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial. Marciniak CM, Harvey RL, Gagnon CM, Duraski SA, Denby FA, McCarty S, Bravi LA, Polo KM, Fierstein KM. Am J Phys Med Rehabil; 2012 Dec 27; 91(12):1007-19. PubMed ID: 23064478 [Abstract] [Full Text] [Related]
5. Clinical effectiveness of ultrasound guided subacromial-subdeltoid bursa injection of botulinum toxin type A in hemiplegic shoulder pain: A retrospective cohort study. Wu T, Song HX, Li YZ, Ye Y, Li JH, Hu XY. Medicine (Baltimore); 2019 Nov 27; 98(45):e17933. PubMed ID: 31702679 [Abstract] [Full Text] [Related]
6. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study. Buyukavci R, Akturk S, Ersoy Y. Eur J Phys Rehabil Med; 2018 Oct 27; 54(5):738-744. PubMed ID: 29422486 [Abstract] [Full Text] [Related]
7. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity. Kong KH, Neo JJ, Chua KS. Clin Rehabil; 2007 Jan 27; 21(1):28-35. PubMed ID: 17213238 [Abstract] [Full Text] [Related]
8. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. Yelnik AP, Colle FM, Bonan IV, Vicaut E. J Neurol Neurosurg Psychiatry; 2007 Aug 27; 78(8):845-8. PubMed ID: 17088333 [Abstract] [Full Text] [Related]
9. A survey of the current practice of intramuscular Botulinum toxin injections for hemiplegic shoulder pain in the UK. Holmes RJ, Connell LA. Disabil Rehabil; 2019 Mar 27; 41(6):720-726. PubMed ID: 29126361 [Abstract] [Full Text] [Related]
10. Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial. Marco E, Duarte E, Vila J, Tejero M, Guillen A, Boza R, Escalada F, Espadaler JM. J Rehabil Med; 2007 Jul 27; 39(6):440-7. PubMed ID: 17624477 [Abstract] [Full Text] [Related]
11. Effectiveness of Botulinum Toxin A in Treatment of Hemiplegic Shoulder Pain: A Systematic Review and Meta-analysis. Xie HM, Guo TT, Sun X, Ge HX, Chen XD, Zhao KJ, Zhang LN. Arch Phys Med Rehabil; 2021 Sep 27; 102(9):1775-1787. PubMed ID: 33454279 [Abstract] [Full Text] [Related]
12. Botulinum toxin injection of the subscapularis muscle. Unlu E, Sen T, Umay E, Bal B, Elhan A, Cakci A. J Clin Neurosci; 2010 Oct 27; 17(10):1265-6. PubMed ID: 20591673 [Abstract] [Full Text] [Related]
13. Treatment of pain and limited movement of the shoulder in hemiplegic patients with botulinum toxin a in the subscapular muscle. Yelnik AP, Colle FM, Bonan IV. Eur Neurol; 2003 Oct 27; 50(2):91-3. PubMed ID: 12944713 [Abstract] [Full Text] [Related]
14. Botulinum Toxin A Injection into the Subscapularis Muscle to Treat Intractable Hemiplegic Shoulder Pain. Choi JG, Shin JH, Kim BR. Ann Rehabil Med; 2016 Aug 27; 40(4):592-9. PubMed ID: 27606265 [Abstract] [Full Text] [Related]
15. Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis. Dong Y, Wu T, Hu X, Wang T. Eur J Phys Rehabil Med; 2017 Apr 27; 53(2):256-267. PubMed ID: 27834471 [Abstract] [Full Text] [Related]
16. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS. Neurorehabil Neural Repair; 2012 Sep 27; 26(7):812-21. PubMed ID: 22371239 [Abstract] [Full Text] [Related]
17. Use of Botulinum Toxin as a Treatment of Hemiplegic Shoulder Pain Syndrome: A Randomized Trial. de Melo Carvalho Rocha E, Riberto M, da Ponte Barbosa R, Geronimo RMP, Menezes-Junior M. Toxins (Basel); 2023 May 11; 15(5):. PubMed ID: 37235361 [Abstract] [Full Text] [Related]
18. Efficacy of two injection-site localisation techniques for botulinum toxin injections: a single-blind, crossover, randomised trial protocol among adults with hemiplegia due to stroke. Morel C, Hauret I, Andant N, Bonnin A, Pereira B, Coudeyre E. BMJ Open; 2016 Nov 15; 6(11):e011751. PubMed ID: 27852706 [Abstract] [Full Text] [Related]
19. Functional impact of different muscle localization techniques for Botulinum neurotoxin A injections in clinical routine management of post-stroke spasticity. Zeuner KE, Knutzen A, Kühl C, Möller B, Hellriegel H, Margraf NG, Deuschl G, Stolze H. Brain Inj; 2017 Nov 15; 31(1):75-82. PubMed ID: 27880052 [Abstract] [Full Text] [Related]
20. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients. Săndulescu MI, Cinteză D, Poenaru D, Potcovaru CG, Păunescu H, Coman OA. Toxins (Basel); 2024 Mar 31; 16(4):. PubMed ID: 38668597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]